344
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prevalence of Dry Eye Disease Among Individuals Scheduled for Cataract Surgery in a Norwegian Cataract Clinic

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 1233-1243 | Received 23 Feb 2023, Accepted 13 Apr 2023, Published online: 27 Apr 2023

References

  • Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf. 2017;15(3):539–574. doi:10.1016/j.jtos.2017.05.001
  • Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15(3):438–510.
  • Nichols KK, Foulks GN, Bron AJ, et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci. 2011;52(4):1922–1929.
  • Lemp MA. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):75–92.
  • Viso E, Rodriguez-Ares MT, Gude F. Prevalence of and associated factors for dry eye in a Spanish adult population (the Salnes Eye Study). Ophthalmic Epidemiol. 2009;16(1):15–21.
  • Hashemi H, Khabazkhoob M, Kheirkhah A, et al. Prevalence of dry eye syndrome in an adult population. Clin Exp Ophthalmol. 2014;42(3):242–248.
  • Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017;15(3):334–365.
  • Moss SE, Klein R, Klein BE. Long-term incidence of dry eye in an older population. Optom Vis Sci. 2008;85(8):668–674.
  • Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118(9):1264–1268.
  • Aldaas KM, Ismail OM, Hakim J, et al. Association of Dry Eye Disease With Dyslipidemia and Statin Use. Am J Ophthalmol. 2020;218:54–58.
  • Gomes JAP, Azar DT, Baudouin C, et al. TFOS DEWS II iatrogenic report. Ocul Surf. 2017;15(3):511–538.
  • Frederick T, Fraufelder FWF, Wiley A. Chambers. In: Clinical Ocular Toxicology. Drugs, Chemicals and Herbs. Philadephia: Elsevier Saunders; 2008.
  • Donthineni PR, Shanbhag SS, Basu S. An Evidence-Based Strategic Approach to Prevention and Treatment of Dry Eye Disease, a Modern Global Epidemic. Healthcare. 2021;9(1):653.
  • Craig JP, Nelson JD, Azar DT, et al. TFOS DEWS II Report Executive Summary. Ocul Surf. 2017;15(4):802–812.
  • Asiedu K, Kyei S, Mensah SN, Ocansey S, Abu LS, Kyere EA. Ocular Surface Disease Index (OSDI) Versus the Standard Patient Evaluation of Eye Dryness (SPEED): a Study of a Nonclinical Sample. Cornea. 2016;35(2):175–180.
  • Epitropoulos AT, Matossian C, Berdy GJ, Malhotra RP, Potvin R. Effect of tear osmolarity on repeatability of keratometry for cataract surgery planning. J Cataract Refract Surg. 2015;41(8):1672–1677.
  • Teshigawara T, Meguro A, Mizuki N. The Effect of Rebamipide on Refractive Accuracy of Cataract Surgery in Patients with Dry Eye. Ophthalmol Ther. 2022;11(2):603–611.
  • Hovanesian J, Epitropoulos A, Donnenfeld ED, Holladay JT. The Effect of Lifitegrast on Refractive Accuracy and Symptoms in Dry Eye Patients Undergoing Cataract Surgery. Clin Ophthalmol. 2020;14:2709–2716.
  • Gupta PK, Drinkwater OJ, VanDusen KW, Brissette AR, Starr CE. Prevalence of ocular surface dysfunction in patients presenting for cataract surgery evaluation. J Cataract Refract Surg. 2018;44(9):1090–1096.
  • Trattler WB, Majmudar PA, Donnenfeld ED, McDonald MB, Stonecipher KG, Goldberg DF. The Prospective Health Assessment of Cataract Patients’ Ocular Surface (PHACO) study: the effect of dry eye. Clin Ophthalmol. 2017;11:1423–1430.
  • Chuang J, Shih KC, Chan TC, Wan KH, Jhanji V, Tong L. Preoperative optimization of ocular surface disease before cataract surgery. J Cataract Refract Surg. 2017;43(12):1596–1607.
  • Miyake K, Yokoi N. Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye: a multicenter prospective randomized study. Clin Ophthalmol. 2017;11:529–540.
  • Gibbons A, Ali TK, Waren DP, Donaldson KE. Causes and correction of dissatisfaction after implantation of presbyopia-correcting intraocular lenses. Clin Ophthalmol. 2016;10:1965–1970.
  • Osmolarity test cards, Instructions for use In: TearLab Corporation HSSSD, CA 92121, USA, ed. Molenstraat 15, 2513 BH The Hague, the Netherlands. 2016.
  • OCULUS Optikgeräte GmbH. Oculus Keratograph Instruction Manual. Wetzlar, Germany: OCULUS Optikgeräte GmbH; 2017.
  • Wu S, Hong J, Tian L, Cui X, Sun X, Xu J. Assessment of Bulbar Redness with a Newly Developed Keratograph. Optom Vis Sci. 2015;92(8):892–899.
  • Herbaut A, Liang H, Denoyer A, Baudouin C, Labbé A. Tear film analysis and evaluation of optical quality: a review of the literature. J Fr Ophtalmol. 2019;42(2):e21–e35.
  • Finis D, Pischel N, Schrader S, Geerling G. Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for Meibomian gland dysfunction. Cornea. 2013;32(12):1549–1553.
  • Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22(7):640–650.
  • de Monchy I, Gendron G, Miceli C, Pogorzalek N, Mariette X, Labetoulle M. Combination of the Schirmer I and phenol red thread tests as a rescue strategy for diagnosis of ocular dryness associated with Sjogren’s syndrome. Invest Ophthalmol Vis Sci. 2011;52(8):5167–5173.
  • Chao C, Stapleton F, Badarudin E, Golebiowski B. Ocular surface sensitivity repeatability with Cochet-Bonnet esthesiometer. Optom Vis Sci. 2015;92(2):183–189.
  • Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology. 2008;115(5):911–915.
  • Tian YJ, Liu Y, Zou HD, et al. 上海市江宁街道20岁及以上人群干眼的流行病学调查[Epidemiologic study of dry eye in populations equal or over 20 years old in Jiangning District of Shanghai]. Zhonghua Yan Ke Za Zhi. 2009;45(6):486–491. Chinese.
  • Millán A, Viso E, Gude F, Parafita-Fernández A, Moraña N, Rodríguez-Ares MT. Incidence and Risk Factors of Dry Eye in a Spanish Adult Population: 11-Year Follow-Up From the Salnés Eye Study. Cornea. 2018;37(12):1527–1534.
  • Malet F, Le Goff M, Colin J, et al. Dry eye disease in French elderly subjects: the Alienor Study. Acta Ophthalmol. 2014;92(6):e429–436.
  • Noor NA, Rahayu T, Gondhowiardjo TD. Prevalence of Dry Eye and its Subtypes in an Elderly Population with Cataracts in Indonesia. Clin Ophthalmol. 2020;14:2143–2150.
  • Farrand KF, Fridman M, Stillman I, Schaumberg DA. Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older. Am J Ophthalmol. 2017;182:90–98.
  • Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136(2):318–326.
  • Jie Y, Xu L, Wu YY, Jonas JB. Prevalence of dry eye among adult Chinese in the Beijing Eye Study. Eye. 2009;23(3):688–693.
  • Yazdani M, Chen X, Tashbayev B, et al. Tear Production Levels and Dry Eye Disease Severity in a Large Norwegian Cohort. Curr Eye Res. 2018;43(12):1465–1470.
  • Sidaraite A, Mikalauskiene L, Grzybowski A, Zemaitiene R. Evaluation of Ocular Surface after Cataract Surgery-A Prospective Study. J Clin Med. 2022;11:15.
  • Kohli P, Arya SK, Raj A, Handa U. Changes in ocular surface status after phacoemulsification in patients with senile cataract. Int Ophthalmol. 2019;39(6):1345–1353.
  • Begley CG, Chalmers RL, Abetz L, et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci. 2003;44(11):4753–4761.
  • Adatia FA, Michaeli-Cohen A, Naor J, Caffery B, Bookman A, Slomovic A. Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjögren’s syndrome. Can J Ophthalmol. 2004;39(7):767–771.
  • Mizuno Y, Yamada M, Miyake Y. Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome. Jpn J Ophthalmol. 2010;54(4):259–265.
  • Sullivan BD, Whitmer D, Nichols KK, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci. 2010;51(12):6125–6130.
  • Lee JH, Kim CH, Choe CM, Choi TH. Correlation Analysis between Ocular Surface Parameters with Subjective Symptom Severity in Dry Eye Disease. Korean J Ophthalmol. 2020;34(3):203–209.
  • Blackie CA, Solomon JD, Scaffidi RC, Greiner JV, Lemp MA, Korb DR. The relationship between dry eye symptoms and lipid layer thickness. Cornea. 2009;28(7):789–794.